Prempro Verdict for Punitive Damages Reduced by Judge
A Pennsylvania judge has slashed a jury’s $78.7 million award in a Prempro breast cancer lawsuit, saying that the punitive damage portion of the verdict was excessive.
A Pennsylvania judge has slashed a jury’s $78.7 million award in a Prempro breast cancer lawsuit, saying that the punitive damage portion of the verdict was excessive.
More than 100 hormone replacement therapy lawsuits filed by women who developed breast cancer after using Prempro and other drugs have been reinstated by a federal appeals court, which ruled…
A New York judge has dismissed 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer, saying that the risk of developing breast cancer from the drugs was…
Researchers indicate that preliminary findings of an ongoing study suggest that health risks associated with a class of older chemotherapy drugs, known as anthracyclines, may outweigh the benefits provide for…
A Philadelphia jury hit subsidiaries of Pfizer, Inc. with $28 million in punitive damages on Monday in a lawsuit over Prempro hormone replacement therapy filed by Donna Kendall. Following the…
A Philadelphia jury has awarded an Illinois woman $6.3 million in compensatory damages in a lawsuit over Prempro and Provera hormone replacement therapy (HRT) drugs, which the plaintiff alleged was…
A federal appeals court has backed a judge’s decision to vacate a $27 million punitive damages award issued in a 2008 Prempro lawsuit filed by a woman who developed breast…
In the second phase of a trial against Wyeth over their hormone replacement therapy (HRT) Prempro, a Philadelphia jury has determined that Wyeth purposefully hid the risk of breast cancer…
A Philadelphia jury has ruled that side effects of Prempro, a hormone-replacement therapy drug manufactured by Wyeth, were a proximate cause of an Illinois woman’s breast cancer and determined that…
A new study indicates that long-term use of the breast cancer drug Tamoxifen can increase the risk that women will develop a rare and aggressive form of aggressive breast cancer.